NPI: 1891039210 · CAMDEN, AR 71701 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/26/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/26/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,504 | $183K |
| 2019 | 19,289 | $137K |
| 2020 | 18,425 | $181K |
| 2021 | 16,244 | $94K |
| 2022 | 11,602 | $111K |
| 2023 | 4,812 | $77K |
| 2024 | 2,196 | $33K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,656 | 2,154 | $250K |
| 83970 | 1,354 | 1,205 | $191K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,922 | 1,523 | $111K |
| 82728 | 617 | 555 | $62K | |
| 82108 | 237 | 207 | $48K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,713 | 1,393 | $47K |
| 83550 | 591 | 538 | $27K | |
| 83540 | 677 | 613 | $26K | |
| A4657 | Syringe, with or without needle, each | 1,795 | 1,471 | $17K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,802 | 444 | $11K |
| 85041 | 1,418 | 1,252 | $7K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 309 | 173 | $7K |
| 85045 | 1,219 | 1,068 | $6K | |
| 85048 | 1,420 | 1,254 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | 4,099 | 937 | $909.88 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 125 | 90 | $123.68 |
| G0008 | Administration of influenza virus vaccine | 76 | 62 | $12.67 |
| 90674 | 42 | 32 | $0.00 |